Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes (TILs)
in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists …

Purpose Previous preclinical and clinical data suggest that the immune system influences
prognosis and response to chemotherapy (CT); however, clinical relevance has yet to be …

The clinical relevance of the host immune system in breast cancer has long been unexplored.
Studies developed over the past decade have highlighted the biological heterogeneity of …

The newly published World Health Organization (WHO) Classification of Tumours of the
breast features significant changes compared to earlier editions. In this review, we outline the …

Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells,
endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by …

Importance The presence of tumor-infiltrating lymphocytes (TILs) is associated with improved
outcomes in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer …

CD4 + T cells are critical regulators of immune responses, but their functional role in human
breast cancer is relatively unknown. The goal of this study was to produce an image of CD4 …

Background The focus of tumour-specific antigen analyses has been on single nucleotide
variants (SNVs), with the contribution of small insertions and deletions (indels) less well …

Ki67 immunohistochemistry (IHC), commonly used as a proliferation marker in breast cancer,
has limited value for treatment decisions due to questionable analytical validity. The …

The quantity of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) is a robust
prognostic factor for improved patient survival, particularly in triple-negative and HER2-…